Multi-Parameter Analysis of Tear Film of Healthy and Suspected Dry Eye Patients using TeaRx Non-Invasive Point-of-care Testing Device: An Investigator Initiated Academic Trial

V Prasad Eye Institute0 个研究点目标入组 0 人开始时间: 待定最近更新: 2021年11月24日

研究概览

暂无简介。

•1.Be 18 years of age and may be of any race and either gender;
•2.2.Be able to read, sign, and date the IRB approved informed consent Additionally, the informed consent must be signed and dated by the individual consenting the subject;
•3.3.Agree for samples to be taken from both eyes;
•4.4.Be willing to follow the study procedures and visit schedule;
•5.5.Meet the applicable DED criteria or Negative Control

•1. Allergy to topical anesthetic or fluorescein dye
•2.Prior eye injury, trauma, or ocular surgery within the last 3 months.
•3.Known blockage of the lacrimal drainage system
•4.Contact lens wear in the last week
•5.Previous corneal refractive surgery including RK, LASIK or PRK surgery
•6.Have an active ocular infection or history of a recent ocular infection in the last two weeks
•7.Have active intraocular inflammation or history of intraocular inflammation, e.g. Uveitis
•8.Use of oral doxycycline, corticosteroids, or immunomodulators in the last month
•9.Have received topical ocular corticosteroids, topical Nonsteroidal (NSAIDs) therapy, or topical ocular cyclosporine in the last month
•10.Pregnant or lactating
•11.Use of any topical ophthalmic medications in the last week (except artificial tears unless used less than 2 hours prior to enrollment)

发起方

V Prasad Eye Institute